Tigecycline Does Not Prolong Corrected QT Intervals in Healthy Subjects

We evaluated the effect of tigecycline (50-mg and 200-mg doses) on corrected QT (QTc) intervals and assessed safety and tolerability in a randomized, placebo-controlled, four-period crossover study of 48 (44 male) healthy volunteers aged 22 to 53 years. Fed subjects received tigecycline (50 mg or 20...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Korth-Bradley, Joan M., McGovern, Paul C., Salageanu, Joanne, Matschke, Kyle, Plotka, Anna, Pawlak, Sylvester
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 2013
Ämnen:
Clinical Therapeutics
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3623319/
https://ncbi.nlm.nih.gov/pubmed/23403419
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01576-12
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk